232280-88-5 Usage
Uses
Used in Pharmaceutical Industry:
5-AMINOMETHYL-THIOPHENE-3-CARBONITRILE is used as an intermediate in the synthesis and production of various pharmaceuticals. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 5-AMINOMETHYL-THIOPHENE-3-CARBONITRILE is utilized as a key component in the creation of agrochemicals, contributing to the development of effective pest control agents and other agricultural products.
Used in Organic Synthesis:
5-AMINOMETHYL-THIOPHENE-3-CARBONITRILE serves as a building block in organic synthesis, enabling the preparation of various functionalized thiophene derivatives. These derivatives can be further utilized in the development of new compounds with specific properties and applications.
Used in Material Science:
5-AMINOMETHYL-THIOPHENE-3-CARBONITRILE has shown potential for use in the development of new materials, making it a subject of research for its possible contributions to material science and the creation of innovative materials with unique properties.
Used in Biological Research:
5-AMINOMETHYL-THIOPHENE-3-CARBONITRILE has been the focus of research for its potential biological activities, indicating that it may have applications in the study and development of new biologically active compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 232280-88-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,3,2,2,8 and 0 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 232280-88:
(8*2)+(7*3)+(6*2)+(5*2)+(4*8)+(3*0)+(2*8)+(1*8)=115
115 % 10 = 5
So 232280-88-5 is a valid CAS Registry Number.
232280-88-5Relevant academic research and scientific papers
PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS
-
Page/Page column 346-349, (2020/10/18)
This disclosure provides pharmaceutical compounds to treat medical disorders, such as complement-mediated disorders, including complement Cl -mediated disorders.
Thrombin inhibitors
-
Page column 33, (2010/02/06)
Novel five-membered heterocyclic amidines, their preparation and use as competitive inhibitors of trypsin-like serine proteases, especially thrombin and kininogenases such as kallikrein. Pharmaceutical compositions which contain the compounds as active ingredients, and use of the compounds as thrombin inhibitors, anticoagulants and antiinflammatory agents.
Noncovalent tripeptidic thrombin inhibitors incorporating amidrazone, amine and amidine functions at P1
Lee, Koo,Jung, Won-Hyuk,Park, Cheol Won,Park, Hee Dong,Lee, Sun Hwa,Kwon, O Hwan
, p. 1017 - 1022 (2007/10/03)
A series of noncovalent tripeptidic thrombin inhibitors incorporating amidrazone, amine and amidine functions at P1 was investigated. While the amidrazone and the amine series displayed limited oral absorption, the amidine series demonstrated generally good oral absorption and strong antithrombotic activity; the single-digit picomolar Ki achieved from this series is among the best yet reported. The present work highlights the benzamidine compound 11f (LB30812) that exhibits excellent overall profiles of potency, oral absorption and antithrombotic efficacy.
